Procaps Group Reports Fourth Quarter and Full Year 2022 Resu

Constant Currency Net Revenues Increased 7% Year-over-Year in 2022, With Strong Demand of RX and Softgel Portfolios, Offset by Clinical Specialty Covid PortfolioPreliminary Results for 1Q23 Show a Significant Rebound from 4Q22 Performance, Company Expects to Reach at Least High Single-Digit Growth in Adjusted EBITDA...

Related Keywords

United States , Florida , Barranquilla , Atláico , Colombia , West Palm Beach , Grupo Somar , Ruben Minski , Grupo Farmac , Patricio Vargas , Toll International , Ii Union , Exchange Commission , Al Soar Netherlands Bv Somar Holding , Company To Host Conference Call , Union Acquisition Corp , Procaps Group , Product Development Market Expansion , International Financial Reporting Standards , Somar Holding , International Accounting Standards Board , Constant Currency Net Revenues Increased , With Strong Demand , Softgel Portfolios , Clinical Specialty Covid , Significant Rebound , Company Expects , Least High Single Digit Growth , Value Creation Initiatives Implemented , Targeted Recurring , Host Conference Call , Webcast Monday , Value Creation Initiatives , Clinical Specialties , Chief Executive Officer , Chief Financial Officer , Learning Release , Call Information , Net Debt To Adjusted , Contribution Margin , Union Acquisition , Business Combination ,